BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22371643)

  • 1. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.
    Zheng XY; Wei RB; Tang L; Li P; Zheng XD
    World J Gastroenterol; 2012 Feb; 18(8):821-32. PubMed ID: 22371643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the efficacy and safety of nucleotide/nucleoside analog monotherapy for hepatitis B virus-associated glomerulonephritis.
    Wang WN; Wu MY; Ma FZ; Sun T; Xu ZG
    Clin Nephrol; 2016 Jan; 85(1):21-9. PubMed ID: 26636326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis.
    Zhang Y; Zhou JH; Yin XL; Wang FY
    World J Gastroenterol; 2010 Feb; 16(6):770-7. PubMed ID: 20135728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Serum DNA Replication, Clinicopathological Characteristics and Prognosis of Hepatitis B Virus-associated Glomerulonephritis with Severe Proteinuria by Lamivudine Plus Adefovir Dipivoxil Combination Therapy.
    Jiang W; Liu T; Dong H; Xu Y; Liu LQ; Guan GJ; Liu XC
    Biomed Environ Sci; 2015 Mar; 28(3):206-13. PubMed ID: 25800445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological characteristics of 5 children with HBV surface antigen (HBsAg)-negative hepatitis B virus-associated glomerulonephritis.
    Liu T; Yang S; Yue Z; Kuang Y; Guan W; Sun L
    J Clin Virol; 2015 May; 66():1-5. PubMed ID: 25866326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of tacrolimus and entecavir combination therapy in the treatment of hepatitis B virus-associated glomerulonephritis: a multi-center, placebo controlled, and single-blind randomized trial.
    Xie XF; Xie BY; Zhang WH; Hou JH; Liu DL; Zhang L; Xu LX; Li ZL; Li RZ; Ye ZM
    Ann Palliat Med; 2022 May; 11(5):1762-1773. PubMed ID: 35672893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon.
    Chung DR; Yang WS; Kim SB; Yu E; Chung YH; Lee Y; Park JS
    Am J Nephrol; 1997; 17(2):112-7. PubMed ID: 9096440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
    Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials.
    Fabrizi F; Bruchfeld A; Mangano S; Dixit V; Messa P; Martin P
    Int J Artif Organs; 2007 Mar; 30(3):212-9. PubMed ID: 17417760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of adefovir dipivoxil combined with a corticosteroid in 38 cases of nephrotic syndrome induced by hepatitis B virus-associated glomerulonephritis.
    Li H; Yuan X; Qiu L; Zhou Q; Xiao P
    Ren Fail; 2014 Oct; 36(9):1404-6. PubMed ID: 25246340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of anti-viral therapy for Hepatitis B virus-associated glomerulonephritis: A meta-analysis.
    Fu B; Ji Y; Hu S; Ren T; Bhuva MS; Li G; Yang H
    PLoS One; 2020; 15(1):e0227532. PubMed ID: 31940324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis.
    Fabrizi F; Dixit V; Martin P
    Aliment Pharmacol Ther; 2006 Sep; 24(5):781-8. PubMed ID: 16918881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroconversion of hepatitis B envelope antigen by entecavir in a child with hepatitis B virus-related membranous nephropathy.
    Igarashi T; Shimizu A; Igarashi T; Hanaoka K; Yoshizaki K; Shigemori T; Shimizu S; Komeichi H; Itoh Y
    J Nippon Med Sch; 2013; 80(5):387-95. PubMed ID: 24189358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: A systematic review and meta-analysis.
    Yi Z; Jie YW; Nan Z
    Ann Hepatol; 2011; 10(2):165-73. PubMed ID: 21502678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Long-Term Corticosteroid Monotherapy in 26 Cases of Nephrotic Syndrome with Biopsy-Proven Membranous Nephropathy Induced by Seronegative Hepatitis B Virus-Associated Glomerulonephritis.
    Zhang Y; Chen S; Yang D; Liu J; Zhang X; Yang X; Han H; Yang D
    Nephron; 2021; 145(2):113-122. PubMed ID: 33561853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with lamivudine and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker for hepatitis B virus-associated glomerulonephritis with mild to moderate proteinuria: a clinical review of 38 cases.
    Sun LJ; Shan JP; Cui RL; Yuan WJ; Jiang GR
    Int Urol Nephrol; 2017 Jun; 49(6):1049-1056. PubMed ID: 28283858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B-related glomerulonephritis and optimization of treatment.
    Liu Y; Shi C; Fan J; Wang B; Li G
    Expert Rev Gastroenterol Hepatol; 2020 Feb; 14(2):113-125. PubMed ID: 31951758
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of telbivudine and entecavir for HBeAg-positive chronic hepatitis B: a meta-analysis.
    Su QM; Ye XG
    World J Gastroenterol; 2012 Nov; 18(43):6290-301. PubMed ID: 23180951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
    Yang Y; Ma YP; Chen DP; Zhuo L; Li WG
    PLoS One; 2016; 11(9):e0160437. PubMed ID: 27598699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of antiviral prophylaxis increased the risk of hepatitis B virus reactivation in glomerulonephritis patients under immunotherapy: a real-life observation.
    Fang J; Li W; Tan M; Chen W; Zhang C; Wang W; Xu Q; Guo X
    Int Urol Nephrol; 2018 Sep; 50(9):1653-1660. PubMed ID: 29644524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.